News for IGM Biosciences, Inc. (1K0.F)

Published at

Feb 26, 2021 8:51 AM

by prnewswire.com

positive

positive

Medivir AB - Year-end Report January - December 2020

/PRNewswire/ -- Promising clinical results, successful business development and secured financing October - December Financial summary for the quarter Net...

MVRBF MVR.SG MVR.MU MVR.F MVR.BE IGMS 1K0.MU 1K0.F

Read more →
Published at

Jan 12, 2021 4:22 AM

by prnewswire.com

positive

positive

Medivir enters into exclusive licensing agreement with IGM Biosciences for birinapant

/PRNewswire/ -- Medivir AB (publ) (Nasdaq Stockholm: MVIR) today announced that it has entered into an exclusive licensing agreement, through which IGM...

MVRBF MVR.SG MVR.MU MVR.F MVR.BE IGMS 1K0.MU 1K0.F

Read more →
Published at

Jan 12, 2021 12:00 AM

by markets.businessinsider.com

positive

positive

IGM Biosciences Enters into Exclusive Licensing Agreement with Medivir for Birinapant

MOUNTAIN VIEW, Calif., Jan. 11, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS) today announced that it has entered into an exclus...

MVRBF MVR.SG MVR.MU MVR.F MVR.BE IGMS 1K0.MU 1K0.F

Read more →
Published at

Jan 7, 2021 1:00 PM

by benzinga.com

positive

positive

IGM Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference

MOUNTAIN VIEW, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (NASDAQ:IGMS), a clinical-stage biotechnology company focused on creating and ...

IGMS 1K0.MU 1K0.F

Read more →